Clinical Trial

Shockwave Therapy in Lower Limb Intermittent Calf Claudication

Study acronym: ESWT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Peripheral arterial disease is a common condition affecting approximately 64% of 56-77 year olds. This condition restricts bloody supply to calf muscles. Pain occurs after walking a short distance and increases in intensity until the person stops, where the pain then gradually subsides. It can be limiting or occasionally debilitating and has been shown to have considerable deleterious effects of patients quality of life. Shock wave therapy has been shown to promote new blood vessel formation and improved healing amongst other findings. This study aims to identify whether shock wave therapy that is applied to the calf muscles causes such an effect to improve the blood supply to the calf muscles, reduce pain, improve walking ability and quality of life.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2016-01-08; most recent amendment 2026-06-16.
Status change: Recruiting → Active, Not Recruiting 2021-02-08
Trial Details
NCT Number NCT02652078
Lead Sponsor Hull University Teaching Hospitals NHS Trust
Collaborators: University of Hull
Conditions Peripheral Vascular Disease
Enrollment 138 participants
Start Date 2015-05-11
Primary Completion 2020-07-31 (estimated)
Study Completion 2030-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-18